Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
[1] [2] Increasing levels of CD38, a membrane-bound NADase that destroys both NAD+ and its precursor nicotinamide mononucleotide, are thought to be the cause of the age-related decline in NAD+ levels, according to a 2016 study in mice, which exhibit age-related declines in NAD+ levels similar to those seen in humans
Staying hydrated and maintaining a balanced diet can further support your bodys response to glutathione therapy
View Protocol Complete dosage protocol and reconstitution guide for SLU-PP-332 (5 mg Vial)
C.WangC
Because the two pathways are convergent but mechanistically distinct, research has documented combined GHRH and GHRP stimulation amplifying GH secretion beyond additive effects, and their differing pharmacokinetics create temporal activation patterns that more closely mimic physiological GH pulsatility than single-agent stimulation
Quick Facts TypePeptide Blend (BPC-157 + TB-500) CategoryRecovery / Tissue Repair AdministrationSubcutaneous injection FrequencyDaily (loading) / 3x weekly (maintenance) Typical Dose250500 mcg of each per dose Cycle Length48 weeks Available Sizes5 mg/5 mg (10 mg total) vials Stability21 days after reconstitution Overview What is the BPC-157 / TB-500 Blend
US$ 21.66
US$ 19.98
US$ 24.29
US$ 23.63
